Related Experiment Videos
Can fetal antigens be used for prophylactic immunization?
Ciba Foundation Symposium
|January 1, 1983
Summary
Researchers explored alternative cells for tumor protection, finding testicular and thymic cells effective in mice. Fetal cells, testicular cells, and thymus cells show cross-reactivity with anti-embryo antibodies, suggesting potential therapeutic applications in cancer research.
Area of Science:
- Immunology
- Oncology
- Developmental Biology
Background:
- Fetal tissues are effective for tumor protection but not feasible for human use.
- Exploring alternative adult cells for tumor immunotherapy is crucial.
Purpose of the Study:
- To evaluate the efficacy of syngeneic spermatozoa, teratocarcinoma cells, testicular cells, and thymic cells as substitutes for fetal cells in protecting against chemically induced tumors.
- To investigate the immunological cross-reactivity between fetal tissues, testicular cells, and thymus cells.
Main Methods:
- Mice were inoculated with 3-methylcholanthrene to induce tumors.
- Various cell types, including syngeneic spermatozoa, teratocarcinoma cells, testicular cells, and thymic cells, were tested for their protective effects.
- Immunological cross-reactivity was assessed using anti-embryo antibodies.
Main Results:
- Syngeneic spermatozoa and teratocarcinoma cells did not protect against tumors.
- Testicular and thymic cells demonstrated effective tumor protection in several experiments.
- Testicular cells exhibited 'enhancement' similar to fetal cells, while thymic cells did not.
- Cross-reactivity was observed between fetal tissues, testicular cells, and thymus cells with anti-embryo antibodies.
Conclusions:
- Testicular and thymic cells show promise as alternatives to fetal tissues for tumor protection.
- The immunological similarities between fetal, testicular, and thymic cells warrant further investigation.
- Variability in results suggests the need for more sensitive test systems to evaluate low degrees of protection.